Is MOBI or ATEC more profitable?

Mobia Medical has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. Mobia Medical's return on equity of 0.00% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Mobia Medical N/A N/A N/A Alphatec -13.49% -6,752.24% -13.88%

Does the media prefer MOBI or ATEC?

In the previous week, Mobia Medical had 5 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for Mobia Medical and 2 mentions for Alphatec. Mobia Medical's average media sentiment score of 1.76 beat Alphatec's score of 1.47 indicating that Mobia Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mobia Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Alphatec 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, CNMD or MOBI?

CONMED has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 1.12 $47.06M $1.85 27.85 Mobia Medical $32.04M 11.41 -$46.50M -$20.18 N/A

Does the media refer more to CNMD or MOBI?

In the previous week, Mobia Medical had 3 more articles in the media than CONMED. MarketBeat recorded 7 mentions for Mobia Medical and 4 mentions for CONMED. Mobia Medical's average media sentiment score of 1.76 beat CONMED's score of 0.47 indicating that Mobia Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Mobia Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Is ENOV or MOBI more profitable?

Mobia Medical has a net margin of 0.00% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Mobia Medical's return on equity. Company Net Margins Return on Equity Return on Assets Enovis -47.96% 12.03% 4.91% Mobia Medical N/A N/A N/A

Does the media favor ENOV or MOBI?

In the previous week, Enovis had 2 more articles in the media than Mobia Medical. MarketBeat recorded 9 mentions for Enovis and 7 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 1.76 beat Enovis' score of 0.45 indicating that Mobia Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Mobia Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to MOBI or IART?

In the previous week, Mobia Medical had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 7 mentions for Mobia Medical and 3 mentions for Integra LifeSciences. Mobia Medical's average media sentiment score of 1.76 beat Integra LifeSciences' score of 1.22 indicating that Mobia Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mobia Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Integra LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AORT or MOBI?

In the previous week, Mobia Medical had 2 more articles in the media than Artivion. MarketBeat recorded 7 mentions for Mobia Medical and 5 mentions for Artivion. Mobia Medical's average media sentiment score of 1.76 beat Artivion's score of 0.66 indicating that Mobia Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mobia Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Mobia Medical (MOBI) Competitors

$10.98 +0.37 (+3.49%)

As of 08/24/2026 04:00 PM Eastern

Compare

MOBI vs. ATEC, CNMD, ENOV, IART, and AORT

Should you buy Mobia Medical stock or one of its competitors? Mobia Medical's main competitors and comparable companies include Alphatec (ATEC), CONMED (CNMD), Enovis (ENOV), Integra LifeSciences (IART), and Artivion (AORT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Mobia Medical compare to Alphatec?

Mobia Medical (NASDAQ:MOBI) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

66.4% of Alphatec shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Mobia Medical had 5 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for Mobia Medical and 2 mentions for Alphatec. Mobia Medical's average media sentiment score of 1.76 beat Alphatec's score of 1.47 indicating that Mobia Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mobia Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Alphatec	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mobia Medical presently has a consensus price target of $20.75, indicating a potential upside of 88.98%. Alphatec has a consensus price target of $17.40, indicating a potential upside of 88.31%. Given Mobia Medical's higher possible upside, equities research analysts clearly believe Mobia Medical is more favorable than Alphatec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Mobia Medical has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. Mobia Medical's return on equity of 0.00% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Alphatec	-13.49%	-6,752.24%	-13.88%

Mobia Medical has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	11.41	-$46.50M	-$20.18	N/A
Alphatec	$764.16M	1.87	-$143.36M	-$0.71	N/A

Summary

Mobia Medical beats Alphatec on 9 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to CONMED?

CONMED (NYSE:CNMD) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Mobia Medical had 3 more articles in the media than CONMED. MarketBeat recorded 7 mentions for Mobia Medical and 4 mentions for CONMED. Mobia Medical's average media sentiment score of 1.76 beat CONMED's score of 0.47 indicating that Mobia Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mobia Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

CONMED has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.12	$47.06M	$1.85	27.85
Mobia Medical	$32.04M	11.41	-$46.50M	-$20.18	N/A

CONMED has a net margin of 4.12% compared to Mobia Medical's net margin of 0.00%. CONMED's return on equity of 14.31% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Mobia Medical	N/A	N/A	N/A

CONMED currently has a consensus target price of $41.40, indicating a potential downside of 19.65%. Mobia Medical has a consensus target price of $20.75, indicating a potential upside of 88.98%. Given Mobia Medical's stronger consensus rating and higher possible upside, analysts plainly believe Mobia Medical is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

CONMED beats Mobia Medical on 7 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to Enovis?

Enovis (NYSE:ENOV) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Mobia Medical has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25B	0.65	-$1.18B	-$19.26	N/A
Mobia Medical	$32.04M	11.41	-$46.50M	-$20.18	N/A

In the previous week, Enovis had 2 more articles in the media than Mobia Medical. MarketBeat recorded 9 mentions for Enovis and 7 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 1.76 beat Enovis' score of 0.45 indicating that Mobia Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mobia Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

98.5% of Enovis shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Mobia Medical has a net margin of 0.00% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
Mobia Medical	N/A	N/A	N/A

Enovis presently has a consensus target price of $41.29, suggesting a potential upside of 64.18%. Mobia Medical has a consensus target price of $20.75, suggesting a potential upside of 88.98%. Given Mobia Medical's higher probable upside, analysts plainly believe Mobia Medical is more favorable than Enovis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Enovis beats Mobia Medical on 9 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to Integra LifeSciences?

Mobia Medical (NASDAQ:MOBI) and Integra LifeSciences (NASDAQ:IART) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Mobia Medical has a net margin of 0.00% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Integra LifeSciences	-0.44%	18.30%	5.30%

Mobia Medical currently has a consensus price target of $20.75, suggesting a potential upside of 88.98%. Integra LifeSciences has a consensus price target of $18.86, suggesting a potential upside of 12.98%. Given Mobia Medical's stronger consensus rating and higher possible upside, analysts plainly believe Mobia Medical is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

84.8% of Integra LifeSciences shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Mobia Medical had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 7 mentions for Mobia Medical and 3 mentions for Integra LifeSciences. Mobia Medical's average media sentiment score of 1.76 beat Integra LifeSciences' score of 1.22 indicating that Mobia Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mobia Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integra LifeSciences	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mobia Medical has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	11.41	-$46.50M	-$20.18	N/A
Integra LifeSciences	$1.64B	0.79	-$516.47M	-$0.09	N/A

Summary

Mobia Medical beats Integra LifeSciences on 9 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to Artivion?

Artivion (NYSE:AORT) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Artivion has higher revenue and earnings than Mobia Medical. Artivion is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.99	$9.77M	-$0.07	N/A
Mobia Medical	$32.04M	11.41	-$46.50M	-$20.18	N/A

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Mobia Medical has a net margin of 0.00% compared to Artivion's net margin of -0.67%. Artivion's return on equity of 6.07% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	-0.67%	6.07%	2.93%
Mobia Medical	N/A	N/A	N/A

In the previous week, Mobia Medical had 2 more articles in the media than Artivion. MarketBeat recorded 7 mentions for Mobia Medical and 5 mentions for Artivion. Mobia Medical's average media sentiment score of 1.76 beat Artivion's score of 0.66 indicating that Mobia Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mobia Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Artivion currently has a consensus price target of $44.83, suggesting a potential upside of 65.62%. Mobia Medical has a consensus price target of $20.75, suggesting a potential upside of 88.98%. Given Mobia Medical's higher possible upside, analysts clearly believe Mobia Medical is more favorable than Artivion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Artivion beats Mobia Medical on 9 of the 15 factors compared between the two stocks.

Get Mobia Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MOBI vs. The Competition

Export

Metric	Mobia Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$353.22M	$5.98B	$7.36B	$12.81B
Dividend Yield	N/A	1.75%	2.54%	10.78%
P/E Ratio	-0.54	26.04	270.56	24.05
Price / Sales	11.41	79.75	639.15	105.26
Price / Cash	N/A	33.71	29.03	36.89
Price / Book	N/A	6.18	11.21	6.40
Net Income	-$46.50M	$149.30M	$3.46B	$347.95M
7 Day Performance	-6.39%	0.45%	1.74%	1.49%
1 Month Performance	1.20%	8.91%	7.34%	5.15%
1 Year Performance	N/A	7.84%	26.13%	17.01%

Mobia Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MOBI Mobia Medical	4.1344 of 5 stars	$10.98 +3.5%	$20.75 +89.0%	N/A	$353.22M	$32.04M	N/A	N/A	Positive News
ATEC Alphatec	3.5417 of 5 stars	$9.79 +0.4%	$17.40 +77.7%	-42.8%	$1.51B	$764.16M	N/A	700
CNMD CONMED	1.9934 of 5 stars	$50.42 +1.2%	$41.40 -17.9%	-7.7%	$1.51B	$1.37B	27.25	3,900	Positive News
ENOV Enovis	4.072 of 5 stars	$26.08 +1.6%	$42.00 +61.0%	-19.9%	$1.50B	$2.25B	N/A	7,802
IART Integra LifeSciences	1.8084 of 5 stars	$18.34 +0.5%	$18.86 +2.8%	+12.3%	$1.43B	$1.64B	N/A	4,427

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MOBI) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mobia Medical (MOBI) Competitors

MOBI vs. ATEC, CNMD, ENOV, IART, and AORT

How does Mobia Medical compare to Alphatec?

Summary

How does Mobia Medical compare to CONMED?

Summary

How does Mobia Medical compare to Enovis?

Summary

How does Mobia Medical compare to Integra LifeSciences?

Summary

How does Mobia Medical compare to Artivion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOBI vs. The Competition

Mobia Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mobia Medical (MOBI) Competitors

MOBI vs. ATEC, CNMD, ENOV, IART, and AORT

How does Mobia Medical compare to Alphatec?

Do institutionals & insiders believe in MOBI or ATEC?

Does the media prefer MOBI or ATEC?

Do analysts recommend MOBI or ATEC?

Is MOBI or ATEC more profitable?

Which has stronger earnings and valuation, MOBI or ATEC?

Summary

How does Mobia Medical compare to CONMED?

Does the media refer more to CNMD or MOBI?

Which has higher earnings & valuation, CNMD or MOBI?

Is CNMD or MOBI more profitable?

Do analysts recommend CNMD or MOBI?

Summary

How does Mobia Medical compare to Enovis?

Which has higher earnings and valuation, ENOV or MOBI?

Does the media favor ENOV or MOBI?

Do institutionals and insiders hold more shares of ENOV or MOBI?

Is ENOV or MOBI more profitable?

Do analysts recommend ENOV or MOBI?

Summary

How does Mobia Medical compare to Integra LifeSciences?

Is MOBI or IART more profitable?

Do analysts prefer MOBI or IART?

Do insiders & institutionals have more ownership in MOBI or IART?

Does the media refer more to MOBI or IART?

Which has better valuation & earnings, MOBI or IART?

Summary

How does Mobia Medical compare to Artivion?

Which has better earnings & valuation, AORT or MOBI?

Do insiders and institutionals have more ownership in AORT or MOBI?

Is AORT or MOBI more profitable?

Does the media refer more to AORT or MOBI?

Do analysts recommend AORT or MOBI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOBI vs. The Competition

Mobia Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools